Tocolysis means drug-induced Inhibition of premature or excessive uterine activity [38] , Other terms, such äs "sedation of the irritated myometrium" or "relaxation of the uterus" have the same meaning; they are, however, not commonly applied [10, 11, 17, 29] . At the beginning of the research for new substances with inhibitory effect on the uterus it was postulated that progesterone or newlydeveloped gestagen preparations could inhibit uterine activity. In vitro äs well äs in vivo experiments showed that progesterone, in concentrations present during pregnancy [37, 56] , exerts a synergistic effect on oxytocin and increases uterine activity. High concentrations which should be applied exclusively for experimental purposes showed the block inaugurated by CSAPO [18]. Together with estrogen, progesterone increases the metabolic activity of the uterus. Prolonged influence leads to relaxation of the tissue and increased uterine weight. The collagen content äs well äs that of nucleic acids, glycogen, and lipids is raised. The sensitivity to exogenous Irritation, e. g. uterine distension by the growing fetus, or to drugs, e. g. oxytocin, increases. Due to the low solubility in water, the considerable affinity to serum protein, and a half-life of 15 minutes, even the highest possible concentrations of progesterone cannot be expected to exert a sufficient effect on the myometrium [31, 36, 54] .
Pharmacology of tocolysis
Cinnamedrine was the first ß-adrenergic substance which, äs reported by SCHULTZ in 1940, showed a relaxant effect on the smooth muscle; however, it soon feil into disuse. In 1960 LISH Curriculum vitae KARL et al. [35] published their findings concerning the relaxant effect on the isolated uterus of the ß-adrenergic substance isoxsuprine. First clinical experiences with isoxsuprine were reported by HENDRICKS et al. [27] and BISHOP et al, [13] in I960. These publications escaped notice in the German-speaking countries for some time. In 1961 we introduced nylidrin (buphenine, Diktol®), a substance of similar composition which had akeady been tested on humans in Germany [17, 38, 55] (Fig. 1) , into the treatment of premature labor. Doses which were eflfective in the Uterus led to considerable side effects. In subsequent years new ^sympathomimetics, kst fenoterol (Th 1165a), were studied experimentally and therapeutically [17, 29, 38, 40] . Substances with a difFetent mode of action, such äs ethyl alcohol [24] , spasmolytic agents of the calcium antagonistic type [23, 40, 41] and, recently, prostagkndin antagonists were also therapeutically tested [2 9 43], To date no drug which acts exlusively or primärily on the myometrium has been found.
/?-Adrenergics
Tocolytics äs such are substances with /?-adrenergic effect on the myometrium. Among all the substances tested for their effcctivcness in the Inhibition of labor, the /9-adrenergics show the best effect with the lowest rate of side effecte. The effect on the uterus represents only one component in the total complex of reactions to adrenergic Irritation. As to the various components of this spectrum, the catechokmines and their derivatives do not show a uniform activity. Two main groups of effects can be characterized. One can be easily induced by norepinephrine but not at all or only slightly by use of isoproterenol The second group is easily induced by isoproterenol, but in most cases not by norepinephrine.
In view of this phenomenon, AHLQUIST [1] postulated two types of adrenergic receptors, a and ß, and two types of adrenergic drugs, <x-adrenergic substances (prototype: noradrenalin) and ßã drenergic substances (prototype: isoproterenol). At present the following pattern of action can be described:
<x-receptors: General excitation of the smooth muscles, in particukr of the vessels; activation of hepatic glycogenolysis. ,-receptors: Positive inotropic, chronotropic and bathmotropic effects on the heart, rekxation of the intestinal muscles, Stimulation of lipolysis, 2 -receptors: Likewise lytic effecte on the intestinal muscles äs well äs on the smooth muscles of bronchi, muscukr arterioles and uterus; activation of the muscular glycogenoiysis. DAVIS et aL [20] regard the receptors äs isoenzymes, According to the pattern of the isoensyme the effect of the agonists of one substance group varies between different individuals and different tissues. At present the /?~receptor is regarded äs an integrating component of the adenyl cyclase System, the ^-adrenejrgic effect being based upon an increase of the intracellular cAMP leveL It is still aot completely clear in which way cAMP leads to the rekxation of the muscle cell and to glycogenolysis, lipolysis and protein synthesis in the cell [52] . SCHILD [46] and RASMUSSEN et al. [45] postulated calcium äs the main factor for the contracting and relaxant efFect of sympathomimetics. According to the efFect of the ß-receptor Stimulation is reflected by an increased formation of cAMP; they assume a Stimulation of the calcium accumulation in the microsomal fraction of the smooth muscle. The effect on the muscular tone äs well äs on the cAMP level can be prevented by£-blockers [4, 5, 6] . In search of new ß-adrenergic substances with better tolerance and increased effectiveness, isoxsuprine (Duvadilan®), nylidrin (Dilatol®) and other derivatives, such äs Ritodrine®, orciprenaline (Alupent®) and the trial drug Th 1165 a fenoterol (Partusisten®) were used experimentally and clinically for the Inhibition of labor [14, 15, 21, 22] . JUNG confirmed that among the tocolytics tested, fenoterol, Th 1165 a (Partusisten®) shows the best results with the lowest dosage. Since 1968 we have applied Th 1165 a routinely in the treatment of premature labor. Using intravenous drip infusion an immediate tocolytic efFect is obtained which can easily be controlled. In selected cases oral administration of Th 1165 a, too, leads to remarkable Inhibition of labor; this efFect is obtained within 20 minutes. The following side-eiFects were observed in 5% of the patients: Restlessness, muscle tremor, sensations of warmth and heat, flushing of the face, nausea. An increased pulse rate occurs in mother and child. When intravenous infusion therapy is used, these Symptoms are generally found only at a dosage of more than 2^g/min. For the evaluation of possible side efFects on the fetus, the whole spectrum of jS-stimulating changes has to be considered; i. e. in addition to positive inotropic and chronotropic efFect and vasodilation in particular metabolic changes such äs glycogenolysis and lipolysis must be mentioned [48] . Seripus sequelae of these side-eiFects have not been reported [42] , « 1.2 Spasmolytics of the papaverine type Those women treated with Dilatol® in our hospital since 1963 complained above all of an uncomfortable increase in heart-rate. Therefore the jff-adrenergic substance was then combined with papaverine (Fig. 2) . The combination of these two compounds with their difFerent modes of action was meant to increase the inhibitory efFect on the uterus, at the same time reducing the side-eiFects described above. In 1914 PAL [44] discovered the relaxant efFect of papaverine on the smooth muscle. In the human uterus high doses lead to reduced tone and decreased frequency of uterine contractions; Inhibition, however, is only obtained with the highest possible concentrations. Paperverine has a negative inotropic efFect on the cardiac muscle and reduces blood pressure by peripheral vasodilation. These and other side-eiFects elicited by the high concentrations required, made the cli- •; ^ ^\jr^·^F ig. 5. Mechanic and electric activity of the isolated rat uterus following Stimulation by oxytocin. In high conĉ entrations aspirin exerts a direct inhibitory effect on the uterine activity. Pig. 7. Ultrasonic cardiotocography in human. Colfarit® (Aspirin®) l g orally, reduces the uterine activity in the case of premature labor. Slow onset and efFect lasting several hours has been observed.
[53] the metabolic side-effects of the /9-sympathomimetics are also decreased by verapamil. Prostaglandins are involved in the process of uterine contractility [30] . average length of gestation, in the incidence of postmaturity, and in the mean duration of spontaneous labor.
. f The possible acting mechanism of Aspirin® is shown in Fig. 8 .
Ethyl alcohol
Ethyl alcohol is recommended for the Inhibition of labor by F. FUCHS [24] . He attributes the labor-inhibiting effect to blocked oxytocin release in the neurohypophysis. J. HÜTER [28] could confirm known labor-inhibiting and basal tone decreasing properties of ethanol in the isolated Uterus of rats and mice; ethyl ether and halothane are also known to possess these properties. Therefore a peripheral point of attack cannot be excluded. With the dosage indicated by F. FUCHS, the blood alcohol level ranges from 0.10 to 0.16%. In addition, adequate intake of häfd liquor tenders oral treatment possible.
Other substances with inhibitory effect on the uterus
Progesterone, gestagen, opiates, and benzodiazepine are only of historical interest, since an inhibitory effect could not be prpved in clinical tests. Relaxin, atropirie, antihistamine, and phenothiazine have also been given without success for the Inhibition of labor [51] . Among the Opiates there are likewise no substances which, in a therapeutically acceptable dosage, could sedate the uterus. These substances may prove detrimental in case of fetal asphyxia and may lead to hypoventilation, especially in the premature fetus. Librium® and Valium® are no· labor-inhibiting agents. Their spasmolytic effect is similar to that of papaverine. With therapeutical dosage intrauterine tocometry did not show any labor-inhibiting effect in humans [7, 8, 9] . In some cases we use benzodiaSepine for psychical sedation äs well. If required, analgetics should also be given. Theophylline is not being used for tocolysis since we have the more effective ß-adrenergic substances and spasmolyti.es. It was recently shown that the effect of theophylline on the nonpregnant human uterus is that of relaxation, independent of the phase of the cycle [16, 19] . Due to toxicity or marked side effects, some substances with tocolytic properties cannot be used äs a routine measure. Intravenoüs application of magnesium Sulfate leads to pronounced reduction in contractioii frequency and amplitude. However, the required blood level concentration of 8 to 12 mg% is very close to the toxic threshold dose [51] , Among the Inhalation anesthetics, ether and Chloroform are known to exert an especially strong effect on the uterus.
J^Perinat. Med. 2 (1974) Chloroform is no longer used because of its narrow therapeutic ränge and the danger of organic lesions. Although ether shows an excellent relaxant effect it cannot be recommended mainly because of the fact t hat it may lead to vomiting with danger of aspiration and hypoxia of the fetus [28] . The pharmacological and anesthesiological properties of halothane are of value for obstetrics: non-inflammability, rapid onset and subsiding of anesthesia without excitation, and rapid tocolysis. If general anesthesia is required, e. g. in case of prolapse of the cord, halothane is the appropriate anesthetic. The following disadvantages are to be mentioned: occasional cardiac irregularities and hypoventilation, insufficient relaxation of the striated muscles, passage into the fetal circulation with danger of hypoxia [28] . Halothane sensitizes the heart to catecholamines. Gases of oxytocin-resistant uterine atony have been reported [51] .
Clinical conditions required for tocolysis
Modern tocolytics are highly effective drugs. Therefore, tocolysis must be restricted to Hospitals staffed with obstetricians. Continuous monitoring and personal observation during treatment should be possible. The development of efficient Instruments in the last few years for the external control of fetal cardiac activity and uterine activity (phonocardio-tocograph (CTG) developed by KAMMACHER [26] , ultrasoniccardio-tocograph (USCTG) developed by MOS-LER [39] ) may be regarded äs advantageous to large-scale clinical application of drugs for the Inhibition of labor.
In particular the diagnosis "increased uterine activity" should be confirmed clinically using tocography. Biliary äs well äs ureteric and intestinal spasms are sometimes mistaken for premature labor. In latter years the number of indications for tocolysis has increased. This supplemented indication list enables a more exact and therefore more successful determination for tocolysis. A reduction in the number of premature deliveries may give rise to hopes of a decrease in perinatal mortality [8, 10, 11, 18, 29, 43] . Initial reports on favorable results obtained with tocolysis are tempered with more pessimistic evaluations [34, 42, 58] .
Successful tocolysis requires certain conditions.
Clinical requirements for tocolysis
a) Coordinate labor with a frequency of l or more contractions within 10 minutes (tocography, partogram). Contractions can often be reduced, by moving the patient into a lateral position. Patients Statements regarding pain during contractions are no reliable criterion for their intensity [28] .
b) The parturient patient must be carrying a live fetus.
c) Estimated fetal weight below 2500 g, or gestation period up to the 37th week.
d) The cervix is dilated not more than 3 cm.
e) The cervix is effaced no more than 50% (pelvic score).
Relative clinical contraindications a) Obstetric contraindications
Premature rupture of the membranes of the lower pole, Temperature above 38°C in case of suspected intrauterine infection, Severe hemorrhage in case of placenta praevia, Premature Separation of the placenta, Cephalo-pelvic-disproportion, and contracted pelvis.
b) Medical contraindications with respect to the fetus
Pathological pattern of the heart rate, Confirmed malformations, Erythroblastosis, Polyhydramnios.
c) Medical contraindications with respect to the mother
Diabetes mellitus which is difficult to stabilize, Hyperthyroidism, Congenital heart disease; heart lesions, e. g. fibrillation.
Owing to the danger of sudden cardiac death, catecholamines should be used very cautiously in cases with coronary sclerosis, hyperthyroidism, and severe hypertension. Concurrent administration of calcium ions increases the tendency to ventricular fibrillation [33] .
In the present article pharmacological contraindications are mentioned only briefly. A detailed description is given in a separate pubücation on the side-effects of /?-adrenergic tocolytics. Druginduced Inhibition o£ premature labor must be preceded by a general medical examination, including auscultation of the heart in particular.
There is almost complete agreement on the clinical conditions required for tocolysis; however, äs to the parameters which are considered relative contraindications widely differing opinions have been published. BIENARZ, CIBILS, FUCHS, and LANDESMAN [59] regard premature rupture of the membranes äs a contraindication because of the danger of ascending infection. On the other hand, KOEPCKE and SEIDENSCHNUR [32] äs well äs WEIDINGER and WIEST [53] report on successful Inhibition of labor following premature rupture. Without tocolysis rupture leads to spontaneous delivery within 3 days in 60% of all cases. In 8% of all cases, the pregnancy is maintained until the end of the gestation period. In the individual case tocolysis may be tried in case of rupture. A Prolongation of the gestation period by more than 8 days should be achieved, this to be weighed against the danger of infection for mother and child. According to our own experience, we regard rupture with considerable loss of amniotic fluid äs a contraindication for tocolysis.
Indications for tocolysis
The main field of application for tocolytics is in threatened premature labor. Premature delivery plays an important part in perinatal mortality [8, 55] . Countries with a low number of premature deliveries have better statistics concerning perinatal mortality, e. g. Sweden äs compared to the USA. Before a treatment is begun, however, we have to ask ourselves if it is advantageous to prevent premature delivery in every case. ZSUSPAN points to the increasing number of children with disturbances of the central nervous System; he finds it difficult to determine to what extent these disturbances can be attributed to prematurity [59] . In our opinion, prophylactic long-term medication is not indicated. "Prophylactic therapy", in case of recurrent premature labor, must be restricted to clinical observation or to regulär supervision in the outpatient clinic. Additional measures must be taken to-solve the problem of premature delivery:
1. Family planning, 2. Adequate prenatal care, 3. Better social condition of the pregnant wo man 4. Inhibition of premature labor äs early äs possible using specific drugs.
On the other hand we approve of prophylactic use of tocolytics in the short-term medication, e. g. after surgical treatment of the uterus in pregnancy. In addition, short-term tocolysis will generally be given to bridge the time until delivery in cases of fetal distress. In case of administration of ß-adrenergic substances for several hours after surgical operations, the development of intestinal atony must be considered. Therefore we use post-operative tocolysis according to the contraction pattern registered by a monitor. The indications for tocolysis listed below will subsequently be briefly cpmmented:
A. Premature labor with excessive uterine activity We do not start tocolysis bef ore the 28th week of gestation because the ß-stimulators have only a weak effect in early pregnancy. JUNG et al. [29] obtained favourable results in the treatment of imminent abortion with a drip infusion during the 2nd to 4th month of pregnancy. 
B. Regulation of labor sub partu

D. Obstetric emergency cases
Complications involving the umbilical cord, Versions and extractions, Manual removal of the placenta.
E. Mild to medium hemorrhage due to placenta praevia up to the 37th week of gestation The decision whether to apply conservative methods in case of placenta praevia bleeding depends on the individual clinical Situation. Even with severe bleeding the uterus may be sedated to prevent further Separation of the placenta until delivery or caesarean section.
F. Intrauterine asphyxia in the course of labor (so-called "intrauterine reanimation" until delivery) As a Symptom for fetal hypoxia, marked deceleration of the chikTs heart-rate may occur during delivery. CALDEYRO-BARCIA et al. [15] äs well äs MOSLER [40] demonstrated successful intrauterine treatment of the fetus in fetal distress by means of administration of orciprenaline or fenoterol (Th 1165 a), respectively, to the mother. In the meantime appropriate measures for completion of parturition may be taken. In some cases delivery can be spontaneous. The blood gas analysis showed an increase of the pH-value under tocolysis [15] J G. Gestosis (reduction in blood-pressure, simultaneous Stimulation of the utero-placental blood-flow, additional infusion of a plasma expander). VAHRSON and SCHWARZ [49] assume an increased utero-placental blood flow, in view of the marked reduction of blood pressure in the mother without danger for the child. ZAPIOLA [57] reported on angiographical studies in pregnant women with increased risk: ^-Stimulation increases human uteroplacental circulation. This therapy, designed to improve the placental ischemia, is problematical in cases already demonstrating alterations of the placenta.
Management of threatened premature labor
We have adopted the following scheme in our clinical management of threatened premature labor
A. Bedrest and mild sedation:
For cases in which continuous uterine monitoring has demonstrated only irregulär premature uterine contractions (prematurity in past medical history).
B. Combined tocolytic-spasmolytic administration:
For cases in which continuous uterine monitoring has demonstrated regulär uterine contractions (prematurity in past medical history).
Immediate treatment -intravenous
Th 1165 a l-3 //g/min Verapamil 120^g/min (administered in 500 ml 5% Glucose).
Long^-term treatment -oral
Th 1165 a 3 mg every 4-6 hours Verapamil 40 mg every 4-6 hours.
If there is no sufficient Inhibition of labor, Aspirin® is given in addition l g every 6 hours for 2-6 days orally or rectally.
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Zusammenfassung Tokolytische Therapie in der Geburtshilfe
Unter Tokolyse versteht man die medikamentöse Hemmung vorzeitiger oder überschießender Uterusaktivität. Progesteron oder inzwischen neuentwickelte GestagenPräparate können die Uterusaktivität des Menschen nicht überzeugend hemmen. Progesteron-Konzentrationen, die in der Schwangerschaft vorkommen, können sogar synergistisch zum Oxytocin wirken und die Uterusaktivität steigern. Nur die im Experiment anwendbaren hohen Konzentrationen zeigen den von CSAPO inaugurierten Block. Bewiesen wurde, daß Progesteron zusammen mit Östrogen die StofFwechselaktivität des Uterus erhöht, es steigert den Kollagen-sowie den Nucleinsäure-, Glykogenund Lipidgehalt. Therapeutisch angewendet kann es wegen seiner geringen Wasserlöslichkeit, der hohen Affinität zum Serumprotein und der kurzen Halbwertzeit auch in höchstmöglichen Konzentrationen keinen ausreichenden Effekt erzielen.
\ 'Pharmakologie der Tokolyse
Die ß-adrenergen Substanzen (Fig. 1) (Fig. 4-6 
Pharmacologie de la tocolyse
Les substances ß-adrenergiques (Fig. 1) (Fig. 3) , peuvent, sous action prolongee, inhiber Pactivite de Puterus et ont valeur des antagomstes des prostaglandines (Fig. 4-6 ). Les prostaglandines de la fraction E 2 etF 2 ocsont considerees comme des mediateurs de Pactivite uterine. L'inhibition de leur Synthese pourrait etre qualifiee de therapie causale si on part du fait que les prostaglandines naturelles conduisent a une activite uterine prematuree ou excessive. Dans quelques cas, on a pu, en Intervention clinique, administrer de Pacide acetyle salicylique sous forme de colfarit® par voie buccale ou de suppositoires d'aspirine® (Fig. 7-8 
